TWO SIGMA ADVISERS, LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2023$2,051,760
+111.9%
124,500
+17.8%
0.01%
+150.0%
Q1 2023$968,212
+45.2%
105,700
+13.5%
0.00%0.0%
Q4 2022$666,596
+38.9%
93,100
-2.8%
0.00%
+100.0%
Q3 2022$480,000
+566.7%
95,800
+224.7%
0.00%
Q2 2022$72,00029,5000.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 4,133,464$45,592,0005.54%
Stonepine Capital Management, LLC 747,863$8,249,0004.45%
JW Asset Management, LLC 444,439$4,902,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$40,320,0002.15%
ARMISTICE CAPITAL, LLC 1,150,000$12,685,0001.62%
FALCON POINT CAPITAL, LLC 855,101$9,432,0001.27%
Perceptive Advisors 1,429,114$15,763,0000.79%
KNOTT DAVID M 126,463$1,395,0000.58%
HEARTLAND ADVISORS INC 700,000$7,721,0000.50%
Sio Capital Management, LLC 91,413$1,008,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders